Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diagnostic Development is a Swedish biotechnology company specializing in the development and manufacturing of diagnostic kits for infectious diseases in both humans and animals. Based in the life science hub of Uppsala, the company is particularly recognized for its expertise in tick-borne pathogens, offering a range of high-performance ELISA kits for detecting Borrelia and Tick-borne encephalitis virus (TBEV). Their products are designed for use in clinical microbiology laboratories and research settings, emphasizing high sensitivity and specificity. Diagnostic Development maintains strong links with Uppsala University and other research institutions to continuously refine its diagnostic technologies. The company's commitment to quality and scientific rigor has made it a trusted provider of diagnostic solutions in the European market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diagnostic Development.